Use APKPure App
Get J3M-MC-JZQB old version APK for Android
Study for patients with KRAS G12C-Mutant, Metastatic Non-Small Cell Lung Cancer
A Multicenter, Randomized, Phase 3 Study Comparing LY3537982 and Pembrolizumab to Placebo and Pembrolizumab as First-Line Treatment in Patients with KRAS G12C-Mutant, Locally Advanced or Metastatic Non-Small Cell Lung Cancer with High PD-L1 Expression (TPS ≥ 50%). This app is specifically intended for participants in the J3M-MC-JZQB study only.Last updated on Jul 2, 2024
Minor bug fixes and improvements. Install or update to the newest version to check it out!
Requires Android
8.0
Category
Report
J3M-MC-JZQB
5.4.700.2-prod by Medable Inc.
Jul 2, 2024